Murray M Pollack1, Richard Holubkov, Tomohiko Funai, Amy Clark, John T Berger, Kathleen Meert, Christopher J L Newth, Thomas Shanley, Frank Moler, Joseph Carcillo, Robert A Berg, Heidi Dalton, David L Wessel, Rick E Harrison, Allan Doctor, J Michael Dean, Tammara L Jenkins. 1. 1Department of Child Health, Phoenix Children's Hospital and University of Arizona College of Medicine-Phoenix, Phoenix, AZ. 2Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT. 3Department of Pediatrics, Children's National Medical Center, Washington, DC. 4Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI. 5Department of Anesthesiology and Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, CA. 6Department of Pediatrics, University of Michigan, Ann Arbor, MI. 7Department of Critical Care Medicine, Children's Hospital of Pittsburgh, Pittsburgh, PA. 8Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA. 9Department of Pediatrics, University of California at Los Angeles, Los Angeles, CA. 10Departments of Pediatrics and Biochemistry, Washington University School of Medicine, St. Louis, MO. 11Pediatric Trauma and Critical Illness Branch, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, the National Institutes of Health, Bethesda, MD.
Abstract
OBJECTIVE: To investigate significant new morbidities associated with pediatric critical care. DESIGN: Randomly selected, prospective cohort. SETTING: PICU patients from eight medical and cardiac PICUs. PATIENTS: This was a randomly selected, prospective cohort of PICU patients from eight medical and cardiac PICUs. MEASUREMENTS AND MAIN RESULTS: The main outcomes measures were hospital discharge functional status measured by Functional Status Scale scores and new morbidity defined as an increase in the Functional Status Scale of more than or equal to 3. Of the 5,017 patients, there were 242 new morbidities (4.8%), 99 PICU deaths (2.0%), and 120 hospital deaths (2.4%). Both morbidity and mortality rates differed (p < 0.001) among the sites. The worst functional status profile was on PICU discharge and improved on hospital discharge. On hospital discharge, the good category decreased from a baseline of 72% to 63%, mild abnormality increased from 10% to 15%, moderate abnormality status increased from 13% to 14%, severe status increased from 4% to 5%, and very severe was unchanged at 1%. The highest new morbidity rates were in the neurological diagnoses (7.3%), acquired cardiovascular disease (5.9%), cancer (5.3%), and congenital cardiovascular disease (4.9%). New morbidities occurred in all ages with more in those under 12 months. New morbidities involved all Functional Status Scale domains with the highest proportions involving respiratory, motor, and feeding dysfunction. CONCLUSIONS: The prevalence of new morbidity was 4.8%, twice the mortality rate, and occurred in essentially all types of patients, in relatively equal proportions, and involved all aspects of function. Compared with historical data, it is possible that pediatric critical care has exchanged improved mortality rates for increased morbidity rates.
OBJECTIVE: To investigate significant new morbidities associated with pediatric critical care. DESIGN: Randomly selected, prospective cohort. SETTING: PICU patients from eight medical and cardiac PICUs. PATIENTS: This was a randomly selected, prospective cohort of PICU patients from eight medical and cardiac PICUs. MEASUREMENTS AND MAIN RESULTS: The main outcomes measures were hospital discharge functional status measured by Functional Status Scale scores and new morbidity defined as an increase in the Functional Status Scale of more than or equal to 3. Of the 5,017 patients, there were 242 new morbidities (4.8%), 99 PICU deaths (2.0%), and 120 hospital deaths (2.4%). Both morbidity and mortality rates differed (p < 0.001) among the sites. The worst functional status profile was on PICU discharge and improved on hospital discharge. On hospital discharge, the good category decreased from a baseline of 72% to 63%, mild abnormality increased from 10% to 15%, moderate abnormality status increased from 13% to 14%, severe status increased from 4% to 5%, and very severe was unchanged at 1%. The highest new morbidity rates were in the neurological diagnoses (7.3%), acquired cardiovascular disease (5.9%), cancer (5.3%), and congenital cardiovascular disease (4.9%). New morbidities occurred in all ages with more in those under 12 months. New morbidities involved all Functional Status Scale domains with the highest proportions involving respiratory, motor, and feeding dysfunction. CONCLUSIONS: The prevalence of new morbidity was 4.8%, twice the mortality rate, and occurred in essentially all types of patients, in relatively equal proportions, and involved all aspects of function. Compared with historical data, it is possible that pediatric critical care has exchanged improved mortality rates for increased morbidity rates.
Authors: Bianca M Buurman; Barbara C van Munster; Johanna C Korevaar; Rob J de Haan; Sophia E de Rooij Journal: J Clin Epidemiol Date: 2010-11-13 Impact factor: 6.437
Authors: Danielle S Burstein; Jeffrey P Jacobs; Jennifer S Li; Shubin Sheng; Sean M O'Brien; Anthony F Rossi; Paul A Checchia; Gil Wernovsky; Karl F Welke; Eric D Peterson; Marshall L Jacobs; Sara K Pasquali Journal: Pediatrics Date: 2011-05-16 Impact factor: 7.124
Authors: Cherry Mammen; Abdullah Al Abbas; Peter Skippen; Helen Nadel; Daniel Levine; J P Collet; Douglas G Matsell Journal: Am J Kidney Dis Date: 2011-12-28 Impact factor: 8.860
Authors: Audun Langhelle; Jerry Nolan; Johan Herlitz; Maaret Castren; Volker Wenzel; Eldar Soreide; Johan Engdahl; Petter Andreas Steen Journal: Resuscitation Date: 2005-09 Impact factor: 5.262
Authors: James W Varni; Christine A Limbers; Katie Neighbors; Kris Schulz; Judith E C Lieu; Robert W Heffer; Krista Tuzinkiewicz; Rita Mangione-Smith; Jerry J Zimmerman; Estella M Alonso Journal: Qual Life Res Date: 2010-08-22 Impact factor: 3.440
Authors: Alicia K Au; Michael J Bell; Ericka L Fink; Rajesh K Aneja; Patrick M Kochanek; Robert S B Clark Journal: Neurocrit Care Date: 2018-02 Impact factor: 3.210
Authors: Tellen D Bennett; Rebecca R Dixon; Cory Kartchner; Peter E DeWitt; Yamila Sierra; Diane Ladell; Allison Kempe; Desmond K Runyan; J Michael Dean; Heather T Keenan Journal: Pediatr Crit Care Med Date: 2016-12 Impact factor: 3.624
Authors: Amery Treble-Barna; Sue R Beers; Amy J Houtrow; Roberto Ortiz-Aguayo; Cynthia Valenta; Meg Stanger; Maddie Chrisman; Maxine Orringer; Craig M Smith; Dorothy Pollon; Mark Duffett; Karen Choong; R Scott Watson; Patrick M Kochanek; Ericka L Fink Journal: Pediatr Crit Care Med Date: 2019-06 Impact factor: 3.624
Authors: Mary E Hartman; Cydni N Williams; Trevor A Hall; Christopher C Bosworth; Juan A Piantino Journal: Pediatr Neurol Date: 2020-02-20 Impact factor: 3.372
Authors: Luisa Flohr; Shaylene Beaudry; K Taneille Johnson; Nicholas West; Catherine M Burns; J Mark Ansermino; Guy A Dumont; David Wensley; Peter Skippen; Matthias Gorges Journal: IEEE J Transl Eng Health Med Date: 2018-03-05 Impact factor: 3.316